SEC Form 4 · accession 0001547959-26-000015
Faeth Therapeutics, Inc. · FTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Saira Ramasastry
Director
Period of report
Jun 12, 2026
Accepted (ET)
Jun 16, 2026 · 4:49 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001829802
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $13.00 | Jun 12, 2026 | A | 25,000 | A | — | Jun 11, 2036 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1The shares subject to the option vest and become exercisable in 36 equal monthly installments over a three year period such that the option is fully vested on the third anniversary of the date of grant, or June 12, 2029, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.